This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Calgary directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
Verbal Memory Performance and Depressive Symptoms in Persons with Treated HIV.
AIDS and behavior · 2023
Plasma microRNAs are associated with domain-specific cognitive function in people with HIV.
AIDS (London, England) · 2021
Construct and Criterion-Related Validity of the Clinical Frailty Scale in Persons With HIV.
Journal of acquired immune deficiency syndromes (1999) · 2021
Latest funding
- $100,000
Trauma Related Experiences; evaluating Impact, enhancing Understanding and Mobilizing interventions to improve outcomes among People with HIV (TRIUMPH)
CIHR · 2024 · Co-investigator
- $434,655
Evaluation of COVID-19 antibodies, cell-mediated immunity and telomeres following COVID-19 immunization or natural infection in an immune compromised population: An HIV Cohort Study
CIHR · 2021 · Principal investigator
- $2,061,000
Stem Cell Network/Réseau de cellules souches
NSERC · 2012 · Co-investigator
34 publications.
Verbal Memory Performance and Depressive Symptoms in Persons with Treated HIV.
Xu L, Gill MJ, Power C, Fujiwara E
Plasma microRNAs are associated with domain-specific cognitive function in people with HIV.
Massanett Aparicio J, Xu Y, Li Y, Colantuoni C, Dastgheyb R, Williams DW, Asahchop EL, McMillian JM, Power C, Fujiwara E, Gill MJ, Rubin LH
Construct and Criterion-Related Validity of the Clinical Frailty Scale in Persons With HIV.
McMillan JM, Gill MJ, Power C, Fujiwara E, Hogan DB, Rubin LH
Predictive variables for peripheral neuropathy in treated HIV type 1 infection revealed by machine learning.
Tu W, Johnson E, Fujiwara E, Gill MJ, Kong L, Power C
Long-term consequences of interpersonal violence experiences on treatment engagement and health status in people living with HIV.
Budd AS, Krentz HB, Rubin LH, Power C, Gill MJ, Fujiwara E
Asymptomatic neurocognitive impairment is a risk for symptomatic decline over a 3-year study period.
Rourke SB, Bekele T, Rachlis A, Kovacs C, Brunetta J, Gill MJ, Carvalhal A, Cysique LA, Marcotte T, Power C
Lifetime antiretroviral exposure and neurocognitive impairment in HIV.
Amusan P, Power C, Gill MJ, Gomez D, Johnson E, Rubin LH, Fujiwara E
Comorbidities in Older Persons with Controlled HIV Infection: Correlations with Frailty Index Subtypes.
McMillan JM, Gill MJ, Power C, Fujiwara E, Hogan DB, Rubin LH
Empiric neurocognitive performance profile discovery and interpretation in HIV infection.
Gomez D, Power C, Gill MJ, Koenig N, Vega R, Fujiwara E
HIV-associated sensory polyneuropathy and neuronal injury are associated with miRNA-455-3p induction.
Asahchop EL, Branton WG, Krishnan A, Chen PA, Yang D, Kong L, Zochodne DW, Brew BJ, Gill MJ, Power C
Trauma Related Experiences; evaluating Impact, enhancing Understanding and Mobilizing interventions to improve outcomes among People with HIV (TRIUMPH)
Principal investigators: Lang, Raynell; Carter-Snell, Catherine J; Gill, Michael J
Keywords: Epidemiology; Hiv; Mental Health; Mixed Methods; Outcomes; Ptsd; Quality Of Life; Risk Factors; Substance Use; Trauma
Evaluation of COVID-19 antibodies, cell-mediated immunity and telomeres following COVID-19 immunization or natural infection in an immune compromised population: An HIV Cohort Study
Principal investigators: Gill, Michael J; Hu, Jia; McMillan, Jacqueline M; Power, Christopher; Riabowol, Karl T
Keywords: Cell Mediated Immunity; Covid-19; Covid-19 Antibody Response; Covid-19 Vaccine; Immune Compromised; Natural Immunity; Persons With Hiv; Telomere Length; Vaccine-Mediated Immunity
Stem Cell Network/Réseau de cellules souches
Principal investigators: Rudnicki, Michael
Stem Cell Network/Réseau de cellules souches
Principal investigators: Rudnicki, Michael
Design of viral vectors for in vivo gene expression
Principal investigators: Power, Christopher
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Christopher Power and Christopher Power: 26 shared papers
- Christopher Power and Esther Fujiwara: 14 shared papers
- Esther Fujiwara and Christopher Power: 10 shared papers
- Christopher Power and Fabrizio Giuliani: 4 shared papers
- Guido van Marle and Christopher Power: 4 shared papers
- Christopher Power and Guido van Marle: 2 shared papers
- Tom Hobman and Christopher Power: 1 shared paper
- Tom Hobman and Guido van Marle: 1 shared paper
- Tom Hobman and Christopher Power: 1 shared paper
- Christopher Power and Paul Kubes: 1 shared paper
- Christopher Power and Jack Jhamandas: 1 shared paper
- Christopher Power and Adriana Carvalhal: 1 shared paper
- Paul Kubes and Christopher Power: 1 shared paper
- Jack Jhamandas and Christopher Power: 1 shared paper
- Jack Jhamandas and Fabrizio Giuliani: 1 shared paper
- Christopher Power and Adriana Carvalhal: 1 shared paper
- Christopher Power and Fabrizio Giuliani: 1 shared paper
- Medicine/Neurology
- Medicine
- Biochemistry and Molecular Biology
- Psychiatry
- Physiology and Pharmacology
- Cell Biology
Co-authors at University of Calgary, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Christopher Power
Medicine/Neurology
26 shared papers, latest 2023
Esther Fujiwara
Medicine
10 shared papers, latest 2023
Guido van Marle
Biochemistry and Molecular Biology
4 shared papers, latest 2007
Adriana Carvalhal
Psychiatry
1 shared papers, latest 2021
Fabrizio Giuliani
Medicine/Neurology
1 shared papers, latest 2013
Tom Hobman
Cell Biology
1 shared papers, latest 2007
Paul Kubes
Physiology and Pharmacology
1 shared papers, latest 2006
Jack Jhamandas
Medicine/Neurology
1 shared papers, latest 2007
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.